Latest Platform Expansion News

hipages Group has acquired a majority stake in VIZ Insurance, marking its strategic entry into the insurance sector for tradies and broadening its platform offerings.

Streamplay Studio delivers a fourth consecutive quarter of positive cash flow, underpinned by steady publishing revenues and strategic platform growth in new regions.

Rent.com.au has achieved a milestone with its first-ever positive operating cashflow of $0.5 million in Q3 FY26, alongside record quarterly revenue of $1.2 million and a 168% surge in recurring revenue.

Netwealth delivered a resilient March quarter with $4 billion in net inflows, pushing total funds under administration to $125.8 billion despite a 3.7% market dip. Growth in Managed Accounts and new intermediary relationships underpin ongoing momentum.

Noxopharm appoints its Chief Scientific Officer Dr Olivier Laczka as CEO, aiming to capitalise on recent clinical successes and expand the Sofra™ technology’s reach in autoimmune and oncology markets.

Freelancer Limited has delivered a landmark FY25 with record profitability, a major NASA contract win, and significant AI-driven growth across its marketplaces and payment services.

Xref Limited reported a 54% jump in annual recurring revenue and a 28% reduction in operational expenses in Q3 FY26, driven by strong platform adoption and strategic integrations with global HR partners.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.

Pureprofile Ltd reported a robust 14.2% increase in revenue and a 21.6% rise in net profit for H1 FY26, driven by international expansion and AI-powered platform growth. The company also announced a strategic acquisition to deepen its market research capabilities.

Freelancer Limited has reported a landmark FY25 with record net profit and revenue growth, powered by strong AI integration and strategic expansion across its core marketplaces.

Butn Limited has reported its fifth consecutive half-year of revenue growth, underpinned by a $100 million senior debt facility and expanding platform originations. Despite a statutory loss, the company’s operational momentum and strategic initiatives signal robust growth prospects.

Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.